- Home
- KOD vs ACR Comparison
KOD vs ACR Comparison
Compare KOD & ACR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- ACR
- Stock Information
- Founded
- KOD 2009
- ACR 2005
- Country
- KOD United States
- ACR United States
- Employees
- KOD N/A
- ACR N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- ACR Real Estate Investment Trusts
- Sector
- KOD Health Care
- ACR Real Estate
- Exchange
- KOD Nasdaq
- ACR Nasdaq
- Market Cap
- KOD 198.4M
- ACR 139.0M
- IPO Year
- KOD 2018
- ACR N/A
- Fundamental
- Price
- KOD $4.81
- ACR $17.73
- Analyst Decision
- KOD Hold
- ACR Buy
- Analyst Count
- KOD 3
- ACR 2
- Target Price
- KOD $9.00
- ACR $17.50
- AVG Volume (30 Days)
- KOD 356.1K
- ACR 78.6K
- Earning Date
- KOD 08-13-2025
- ACR 07-30-2025
- Dividend Yield
- KOD N/A
- ACR N/A
- EPS Growth
- KOD N/A
- ACR N/A
- EPS
- KOD N/A
- ACR 0.34
- Revenue
- KOD N/A
- ACR $83,545,000.00
- Revenue This Year
- KOD N/A
- ACR $3.57
- Revenue Next Year
- KOD N/A
- ACR N/A
- P/E Ratio
- KOD N/A
- ACR $52.14
- Revenue Growth
- KOD N/A
- ACR 6.92
- 52 Week Low
- KOD $1.92
- ACR $13.71
- 52 Week High
- KOD $11.60
- ACR $23.81
- Technical
- Relative Strength Index (RSI)
- KOD 64.94
- ACR 46.92
- Support Level
- KOD $3.70
- ACR $17.69
- Resistance Level
- KOD $4.01
- ACR $18.05
- Average True Range (ATR)
- KOD 0.34
- ACR 0.43
- MACD
- KOD 0.13
- ACR 0.04
- Stochastic Oscillator
- KOD 70.72
- ACR 43.75
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About ACR ACRES Commercial Realty Corp.
ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.